We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CHR:CRYPTOCAPMarket Cap CHR, $ Analysis

Data as of 2026-06-01 - not real-time

$2.59

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading at $2.59, well below its 20‑day SMA of ~1.87 and 50‑day SMA of ~1.98, indicating a bearish price alignment despite a recent bullish MACD histogram of 0.095 and a MACD line that has crossed above the signal line. However, the RSI sits at 66.7, suggesting momentum is strong but not yet in overbought territory. Support sits near $1.53 while resistance caps near $2.68, framing a tight range that the price is testing. Volatility is extreme at 139% over the past 30 days, and beta of 1.14 points to higher‑than‑market swings. The bearish trend direction flag aligns with the price lagging its long‑term 200‑day SMA of $28, underscoring a deep downtrend. Increasing volume adds conviction to the current price action.
Fundamentally, the company trades at a P/E of 0.04 and P/B of 0.01, far below the industry averages of 17× and the DCF‑derived fair value of $176, implying massive undervaluation. Yet the max drawdown of –99.5% and a debt‑to‑equity ratio of 2.55 highlight severe balance‑sheet stress and historic price collapse. Revenue of $149 M grows modestly at 2.2% with healthy gross margins of 71%, and the firm holds $242 M in cash against $9.4 M of debt, providing a liquidity cushion. No dividend is paid, and earnings guidance is absent, limiting income‑focused appeal. The recent 1‑for‑3 reverse split announced to preserve Nasdaq listing may improve share price perception and attract institutional attention. Taken together, the extreme price discount versus intrinsic value is offset by high volatility, regulatory exposure in China’s advertising sector, and a fragile market cap of only $4 M.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish price relative to long‑term SMA
  • Bullish MACD crossover providing short‑term upside
  • Extreme 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Massive valuation gap to DCF fair value
  • Strong cash position versus minimal debt
  • Potential institutional interest after reverse split

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Fundamental undervaluation relative to industry peers
  • Sustainable operating margins and cash flow generation
  • Long‑run growth opportunities in AI‑driven content platforms

Key Metrics & Analysis

Financial Health

Revenue Growth2.20%
Profit Margin17.21%
P/E Ratio0.0
ROE7.59%
ROA4.39%
Debt/Equity2.56
P/B Ratio0.0
Op. Cash Flow$17.9M
Free Cash Flow$2.9M
Industry P/E17.0

Technical Analysis

TrendBearish
RSI66.7
Support$1.53
Resistance$2.68
MA 20$1.87
MA 50$1.98
MA 200$28.05
MACDBullish
VolumeIncreasing
Fear & Greed Index92.86

Valuation

Fair Value$176.24
GradeUndervalued
TypeValue

Risk Assessment

Beta1.14
Volatility139.06%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.